News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Grissinger Michael
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
4
| Grissinger Michael (Director) has filed a Form 4 on Aprea Therapeutics, Inc.|
Txns:
| Granted 500 shares
@ $0
Granted 2,000 options to buy
@ $3.65, valued at
$7.3k
|
|
| 08/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/05/2020 |
4
| Grissinger Michael (Director) has filed a Form 4 on resTORbio, Inc.|
Txns:
| Granted 14,414 options to buy
@ $2.23, valued at
$32.1k
|
|
| 05/09/2019 |
4
| Grissinger Michael (Director) has filed a Form 4 on resTORbio, Inc.|
Txns:
| Granted 14,414 options to buy
@ $7.99, valued at
$115.2k
|
|
| 11/06/2018 |
4
| Grissinger Michael (Director) has filed a Form 4 on resTORbio, Inc.|
Txns:
| Granted 28,828 options to buy
@ $11.82, valued at
$340.7k
|
|
| 11/06/2018 |
3
| Grissinger Michael (Director) has filed a Form 3 on resTORbio, Inc. |
|
|